GILD — GILEAD SCIENCES, INC. catalysts

Name: Bio Catalyst Calendar — source-anchored biotech/pharma catalyst dates
Creator: Bio Catalyst Calendar
License: https://www.usa.gov/government-works

4 verified catalyst event(s) for GILEAD SCIENCES, INC. (ticker GILD). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-07-01 — Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention · official source ↗

Upcoming

Date	Event	Company	Drug	Official source & verification
2026-07 (month) in 9d ESTIMATED	READOUT Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Phase 2 · Pre-Exposure Prophylaxis of HIV Infection	GILD GILEAD SCIENCES, INC.	Lenacapavir Tablet, Lenacapavir Injectio	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change
2026-08 (month) in 1mo ESTIMATED	READOUT Study of Novel Treatment Combination Therapies in Participants With Head and Nec Phase 2 · Head and Neck Squamous Cell Carcinoma	GILD GILEAD SCIENCES, INC.	Domvanalimab, Zimberelimab, Paclitaxel,	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change
2026-09 (month) in 2mo ESTIMATED	READOUT Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chro Phase 2 · Chronic Hepatitis B	GILD GILEAD SCIENCES, INC.	TAF	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change
2026-09 (month) in 2mo ESTIMATED	READOUT Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participa Phase 2 · Non-small Cell Lung Cancer	GILD GILEAD SCIENCES, INC.	Sacituzumab Govitecan-hziy (SG), Pembrol	ClinicalTrials.gov ↗ ✓ Source-checked 2026-06-22 Sponsor-projected date — can change